TW513415B - 4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof - Google Patents
4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof Download PDFInfo
- Publication number
- TW513415B TW513415B TW087101275A TW87101275A TW513415B TW 513415 B TW513415 B TW 513415B TW 087101275 A TW087101275 A TW 087101275A TW 87101275 A TW87101275 A TW 87101275A TW 513415 B TW513415 B TW 513415B
- Authority
- TW
- Taiwan
- Prior art keywords
- scope
- amine
- patent application
- ethyl
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80127697A | 1997-02-18 | 1997-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW513415B true TW513415B (en) | 2002-12-11 |
Family
ID=25180658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW087101275A TW513415B (en) | 1997-02-18 | 1998-02-03 | 4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0973749A1 (ko) |
| JP (1) | JP2001509814A (ko) |
| KR (1) | KR20000071129A (ko) |
| CN (1) | CN1252793A (ko) |
| AR (1) | AR011136A1 (ko) |
| AU (1) | AU746717B2 (ko) |
| BR (1) | BR9807701A (ko) |
| CA (1) | CA2278700A1 (ko) |
| HU (1) | HUP0001302A3 (ko) |
| IL (1) | IL131158A0 (ko) |
| NZ (1) | NZ336969A (ko) |
| TW (1) | TW513415B (ko) |
| WO (1) | WO1998035945A1 (ko) |
| ZA (1) | ZA981309B (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6541502B1 (en) * | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| WO2003075921A2 (en) | 2002-03-05 | 2003-09-18 | Transtech Pharma, Inc. | Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| TWI517850B (zh) | 2009-09-30 | 2016-01-21 | Ｖｔｖ治療有限責任公司 | 經取代之咪唑衍生物及其使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
| SI0707007T1 (en) * | 1994-10-14 | 2002-04-30 | Merck Patent Gmbh | (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ATE234281T1 (de) * | 1996-08-27 | 2003-03-15 | Wyeth Corp | 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden |
-
1998
- 1998-01-13 IL IL13115898A patent/IL131158A0/xx unknown
- 1998-01-13 CA CA002278700A patent/CA2278700A1/en not_active Abandoned
- 1998-01-13 WO PCT/US1998/000613 patent/WO1998035945A1/en not_active Application Discontinuation
- 1998-01-13 CN CN98804249A patent/CN1252793A/zh active Pending
- 1998-01-13 HU HU0001302A patent/HUP0001302A3/hu unknown
- 1998-01-13 JP JP53572798A patent/JP2001509814A/ja active Pending
- 1998-01-13 EP EP98902513A patent/EP0973749A1/en not_active Withdrawn
- 1998-01-13 BR BR9807701-5A patent/BR9807701A/pt not_active IP Right Cessation
- 1998-01-13 AU AU59153/98A patent/AU746717B2/en not_active Ceased
- 1998-01-13 KR KR1019997007418A patent/KR20000071129A/ko not_active Application Discontinuation
- 1998-01-13 NZ NZ336969A patent/NZ336969A/xx unknown
- 1998-02-03 TW TW087101275A patent/TW513415B/zh active
- 1998-02-11 AR ARP980100617A patent/AR011136A1/es not_active Application Discontinuation
- 1998-02-17 ZA ZA9801309A patent/ZA981309B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU746717B2 (en) | 2002-05-02 |
| HUP0001302A3 (en) | 2001-07-30 |
| BR9807701A (pt) | 2000-05-02 |
| CN1252793A (zh) | 2000-05-10 |
| CA2278700A1 (en) | 1998-08-20 |
| WO1998035945A1 (en) | 1998-08-20 |
| EP0973749A1 (en) | 2000-01-26 |
| AR011136A1 (es) | 2000-08-02 |
| AU5915398A (en) | 1998-09-08 |
| NZ336969A (en) | 2001-03-30 |
| JP2001509814A (ja) | 2001-07-24 |
| KR20000071129A (ko) | 2000-11-25 |
| ZA981309B (en) | 1999-08-17 |
| HUP0001302A2 (hu) | 2001-05-28 |
| IL131158A0 (en) | 2001-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5952917B2 (ja) | ベンゾチオフェン化合物又はその塩の、二水和物、及びその製造方法 | |
| KR101477553B1 (ko) | 이소인돌론 화합물 및 대사성 글루타메이트 수용체증강제로서 이들의 용도 | |
| JP5501230B2 (ja) | セロトニン５−ｈｔ６受容体の調節に応答する障害の治療に好適なキノリン化合物 | |
| DE69912279T2 (de) | 5-ht1f agonisten | |
| CN109311843A (zh) | 作为PI3Kβ抑制剂的氮杂苯并咪唑衍生物 | |
| CN102015720A (zh) | 神经元烟碱性受体的选择性配体及其应用 | |
| JP2011516598A (ja) | ニコチン性アセチルコリン受容体サブタイプアルファ−７１のモジュレータとしてのインドール | |
| PL188330B1 (pl) | Dihydrat metanosulfonianu 5-{2-[4-(1,2-benzizotiazol-3-ilo)-1-piperazynylo]etylo}-6-chloro-1,3-dihydro-2H-indol-2-onu i środek farmaceutyczny | |
| JP2003527374A (ja) | １，２，３，４−テトラヒドロイソキノリン誘導体 | |
| PL188164B1 (pl) | Trihydrat metanosulfonianu 5-{2-[4-1,2-benzizotiazol-3-ilo)-1-piperazynylo]etylo}-6-chloro-1,3-dihydro-2H-indol-2-onu i środek farmaceutyczny | |
| TW200538443A (en) | Novel heterocyclic compound | |
| JP2005530763A (ja) | カリウム・チャネル調節物質としてのビス−ベンズイミダゾール及び関連化合物 | |
| TW200300689A (en) | [1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists | |
| PT1753725E (pt) | Derivados de tetra-hidroisoquinolilsulfonamidas, sua preparação e sua utilização em terapia | |
| TW202140467A (zh) | 小分子干擾素基因刺激因子(sting)拮抗劑 | |
| IL260298A (en) | 6,7,8,9-tetrahydro-5h-pyrido [2,3-d] azepine substances and their use as dopamine d3 ligands | |
| DK2718290T3 (en) | Compositions and Methods for Modulating a Kinase | |
| TW513415B (en) | 4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof | |
| TW589315B (en) | 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives | |
| AU2018305223A1 (en) | New propanamine derivatives for treating pain and pain related conditions | |
| DE60005685T2 (de) | Oxazinocarbazole zur behandlung von cns-erkrankungen | |
| JPH09512025A (ja) | ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体 | |
| CN1277607A (zh) | 2－取代的1,2－苯并异噻唑衍生物及其作为血清素拮抗剂(5－ht1a,5－ht1b和5－ht1d)的应用 | |
| PT1645558E (pt) | Piperazinilpirazinas como moduladores do receptor 5-ht2c da serotonina | |
| CA2171782A1 (en) | Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines |